Syndromes
of Ocular or Retrobulbar Pain with Intracranial Disease
Raeder’s
Paratrigeminal Neuralgia: Ophthalmic Division Pain (Cluster Headache)
with Oculosympathetic Palsy
Raeder's
syndrome, or Raeder's paratrigeminal neuralgia, is a condition
characterized by severe, unilateral headache, facial pain, or
dysesthesia that is usually in the distribution of the ophthalmic
division of the trigeminal nerve, combined with an ipsilateral
oculosympathetic palsy (Horner's syndrome). In many cases, there is
associated nasal stuffiness or rhinorrhea. George Raeder, a Norwegian
neurologist, first described in 1918 the association of severe facial
neuralgia and an incomplete Horner's syndrome (sweating was normal on
the side of the lesion) in a patient with a meningioma situated between
the internal carotid artery and the Gasserian ganglion. Raeder suggested
that the site of the painful oculosympathetic palsy was the point where
the oculosympathetic fibers leave the internal carotid artery to join
the ophthalmic division of the trigeminal nerve. In 1924, Raeder
reported this case and four others. In all cases except one, other
cranial nerves were involved. Two of the cases were caused by trauma,
but in two cases, no etiology could be determined. Since these initial
descriptions, many reports of this syndrome have emphasized various
intracranial causes including locally invasive tumors, metastatic tumors
to the middle cranial fossa, acquired and congenital abnormalities of
the internal carotid artery, and inflammation of adjacent structures (Mokri
et al., 1979; see bibliography in Grimson and Thompson, 1980; Harrington
and Mayman, 1983). In fact, by 1950, the term ``Raeder's syndrome''
suggested a serious disease in the middle cranial fossa.
During
the 1950's and 1960's, a second type of ``Raeder's syndrome'' was
identified. Patients with this syndrome had a benign illness without
multiple, para-sellar cranial nerve involvement, a description that fits
only one of the original five cases described by Raeder.
Ford and Walsh (1958) observed 25 cases of the paratrigeminal syndrome
in which only pain above the eyes and the oculosympathetic phenomenon
were present. Males seemed to be affected almost exclusively. The onset
was, as a rule, in middle age or old age. The first symptom was a
throbbing headache located behind, within, or above one eye. It was
invariably severe and began early in the morning, often awakening the
patient from sleep. Frequently, there were associated nausea and
vomiting. Often the pain would cease by midday. The pain occurred every
morning and usually persisted for a number of weeks or even months. As a
rule, the headache was severe for only the first week or two.
Shortly
after the headache began, the ipsilateral eyelid began to droop and the
pupil became smaller. The pupil did not expand in reduced illumination,
so the difference in the size of the pupils was more obvious in a
darkened room. In a bright light, the difference in the pupils was often
very slight. When cocaine was instilled, the affected pupil did not
dilate. The conjunctiva was often somewhat congested for a time. It
seemed clear from these findings that the oculosympathetic nerve fibers
had been damaged in some way. Ford and Walsh (1958) as well as Toussaint
(1959) stressed that this did not represent a complete Horner's
syndrome, since there was no loss of sweating on the face. Skin
resistance to galvanic current was unaltered on the face. They agreed
with Raeder that the lesion must be at the base of the middle fossa.
They further noted that the eyelid lifted and the pupil expanded to its
normal size after a few months or possibly a year. In a few instances, a
second attack occurred.
Ford
and Walsh (1958) were impressed with the stereotyped character of the
syndrome and suspected that it was usually due to a specific cause.
While questioning their patients carefully, they elicited, almost
without exception, a clear history of throbbing morning headaches of
many years' duration, often associated with nausea and vomiting. They
concluded that the syndrome is merely a somewhat unusual result of a
series of severe and frequent ``migrainous'' headaches. In 1955, Harold
Wolff had shown that in a migrainous attack, the arteries become
dilated, and if the attack is prolonged, the wall of the artery becomes
edematous and thickened. The oculosympathetic nerve fibers are within
the sheath of the internal carotid artery where it lies at the base of
the middle fossa adjacent to the trigeminal nerve divisions. Thus,
ischemic changes in the internal carotid artery could damage the
sympathetic fibers and at the same time produce severe pain. That this
appears to be the mechanism in such cases is suggested from the studies
by Ekbom and Greitz (1970) who performed carotid angiography on 18
patients with ``cluster headache.'' In one patient, angiography was
performed before and during an attack. The patient was a 42-year-old man
who was admitted to the hospital with attacks of severe, unilateral
headache associated with conjunctival injection, lacrimation, rhinorrhea,
and ipsilateral ptosis and miosis. An angiogram performed when the
patient was symptom-free showed localized narrowing of the extradural
portion of the internal carotid artery distal to its exit from the
carotid canal. The ophthalmic artery was markedly dilated. The patient
then experienced an attack of eye pain, and an angiogram performed at
that time showed extension of narrowing in a proximal direction as far
as the superior part of the carotid canal.
Following
the report by Ford and Walsh (1958), other investigators described
similar patients (Smith, 1958; Boniuk and Schlezinger, 1962; Minton and
Bounds, 1964; Grimson and Thompson, 1980--see bibliography). Boniuk and
Schlezinger drew similar conclusions to those of Ford and Walsh
regarding the vascular cause of the pain. In two of their patients, they
noted a mild sweating on the forehead of the affected side.
They suggested that in these cases, the oculosympathetic fibers to sweat
glands of the forehead may follow the internal carotid artery to the
ophthalmic artery and from there to the forehead (Nieden, 1884). Klingon
and Smith (1956) made similar observations.
It now
seems clear that the terms ``red migraine,'' ``migrainous neuralgia,''
``ciliary neuralgia,'' ``histamine cephalgia,'' ``Horton's headache,''
and ``cluster headache'' all represent the same syndrome, with most (but
not all) cases being accompanied by oculosympathetic paresis (Spierings,
1980; Vijayan and Watson, 1982; Watson and Vijayan, 1982). Data that
would appear to support this contention include the clinical use of
vasodilators such as nitroglycerine (Ekbom, 1968) or histamine (Horton
et al., 1939; Horton, 1956) to induce a headache during cluster periods
in patients with the paratrigeminal syndrome, the consistent finding of
elevated levels of histamine in the blood and urine of such individuals
during headache attacks, and an elevation of plasma serotonin levels in
some patients (Anthony and Lance, 1971; Medina et al., 1979). In
addition, Medina et al. (1979) reported a reduction in the number of
platelets present in blood samples taken from the external jugular vein
on the side of the headache as compared to samples taken from the
contralateral external jugular vein, and Norris et al. (1976) noted an
increased number of mast cells in the skin overlying the painful facial
areas. Studies using dynamic brain scanning, Doppler and 133Xe
blood flow studies, dynamic tonometry, facial thermography, and carotid
arteriography all indicate that specific changes occur in the
ipsilateral internal and external carotid artery and that alterations in
the vasomotor activity of these vessels may exist between attacks.
Boniuk
and Schlezinger (1962) also noted that the conjunctival injection that
accompanies an attack of the paratrigeminal syndrome may at first be
misdiagnosed as conjunctivitis. In addition, they found that the near
point of accommodation on the side of the sympathetic paralysis was
slightly closer in some of their patients.
Ford
and Walsh (1958), Smith (1958), and others stressed that a case of
paratrigeminal neuralgia in which there are no associated cranial nerve
palsies is a benign syndrome in which symptoms and signs are so
characteristic that extensive neuroradiologic investigations are rarely
indicated. In fact, Grimson and Thompson (1980) have defined three
major categories of Raeder's paratrigeminal neuralgia. Group I includes
patients with either multiple parasellar cranial nerve involvement
(cranial nerves II, III, IV, V, VI) or involvement of the second, third,
or all three divisions of the trigeminal nerve. Group II includes
patients with a ``classic'' history of ``cluster'' headaches (very
severe; pain lasts 30---120 minutes and comes in clusters lasting
several weeks or months; complete absence of pain between attacks and
during months or years separating ``cluster'' periods) and absence of
any neurologic signs other than an oculosympathetic paresis. Group III
consists of patients with a history of pain that is not typical of
cluster headache (frequent variations in severity of pain; lasts for
hours or days; may be continuous over several weeks or months),
associated with signs of involvement of the ophthalmic division of the
trigeminal nerve. In this group, there may be associated systemic
conditions including hypertension, atherosclerosis, a past history of
vascular headaches, head trauma, and recent local infections,
particularly sinusitis.
Grimson
and Thompson (1980) believe that patients who fall into Group I clearly
require a complete neuroradiologic investigation as well as an
otolaryngologic evaluation and possibly a nasopharyngeal biopsy to rule
out the various parasellar mass lesions that may be responsible for the
syndrome. Patients in Group II do not require investigation but can be
treated with medical therapy in anticipation of ultimate resolution of
the process. Patients in Group III also usually have a benign,
self-limited process; however, the physician should search for and treat
any associated systemic or local conditions that may be responsible for
the process, particularly paranasal sinusitis, diabetes mellitus, and
hypertension. In addition, if the headaches do not resolve within
several months or if other neurologic signs develop, a full
neuroradiologic investigation that includes carotid angiography is
warranted. It is interesting that Grimson and Thompson (1980) have
examined six patients with isolated, postganglionic Horner's syndrome
who had no associated pain. These six patients were
considered to have a ``benign'' syndrome similar to those with
associated unilateral headache but without evidence of other cranial
nerve involvement. Dr. Miller has seen such a patient at Walter Reed
Army Medical Center. The patient, a 23-year-old man, had a history of
``sick headaches'' as a child. At 23 years of age, he had the sudden
onset of drooping of his left upper eyelid associated with slight
redness of the left eye but without headache, lacrimation, or nasal
stuffiness. The ptosis cleared spontaneously after several days, but the
patient had several more episodes over the next several weeks, two of
which were associated with ipsilateral headache
above and behind the left eye. The patient stressed to us, however, that
the majority of his episodes were unassociated with
any headache or pain. The patient's examination revealed only a left,
postganglionic Horner's syndrome. No further investigations were
performed.
As
might be expected, there are always exceptions to any rule, so that
although we would agree in principle with the classification and
management proposed by Grimson and Thompson (1980), we would caution the
physician who is treating a patient with a ``Group III'' paratrigeminal
syndrome to follow the patient carefully and repeat the examination of
the cranial nerves at regular intervals to make certain that no new
symptoms or signs appear.
The
severe pain that occurs in patients with the ``benign'' form of the
paratrigeminal syndrome is usually dramatically relieved with
vasoconstrictive agents such as ergotamine tartrate (Grimson and
Thompson, 1980). In addition, methysergide, systemic corticosteroids,
lithium, and the serotonin antagonist BC 105 have all been shown to be
useful in some patients (Ekbom, 1969; Jammes, 1975; Ekbom, 1977; Kudrow,
1977; Couch and Ziegler, 1979; Grimson and Thompson, 1980; Ekbom, 1981).
Meyer et al. (1970) have recommended sphenopalatine ganglionectomy for
those patients who do not respond to medical therapy; however, in our
experience, this therapy is rarely, if ever, indicated. The interested
reader is urged to consult the excellent monograph by Grimson and
Thompson (1980) for a more complete review of this subject. (Further
details concerning the differential diagnosis of oculosympathetic palsy
are considered elsewhere)
Thalamic
division pain as a sign of internal carotid artery dissection has been
discussed earlier under section 6.9: Headache associated with other
vascular disorder.
According
to Dalessio (1993) Raeder’s is summarized as those who had
"multiple cranial nerve involvements, primarily parasellar,
associated with oculosympathetic paralysis and intact facial sweating.
Others have since described almost any lesion in which there is
oculosympathetic paralysis associated with head pain as Raeder’s
syndrome. Given this confusion, it would probably be best to abandon the
eponym and more precisely classify patients with oculosympathetic
paralysis and headache, who may or may not have disturbances of sweating
as well." In my experience eponymic designation such as "Raeder’s
syndrome" or "Tolosa-Hunt syndrome" are often used when a
patient has encountered some features of the original description and it
is assumed, incorrectly, that a diagnosis has been made.
Return to
Other Headaches